Point72 Hong Kong’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Point72 Hong Kong’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,860	Closed	-$17K	–	2603
2021 Q3	$17K	Buy	+2,860	New	+$17.8K	﹤0.01%	1727
2021 Q2	–	Sell	-2,064	Closed	-$18K	–	2513
2021 Q1	$18K	Buy	2,064 +1,573	+320%	+$18K	﹤0.01%	1502
2020 Q4	$6K	Sell	491 -228	-32%	-$2.65K	﹤0.01%	1587
2020 Q3	$7K	Sell	719 -1,613	-69%	-$19.8K	﹤0.01%	1036
2020 Q2	$31K	Buy	+2,332	New	+$24.2K	﹤0.01%	824
2019 Q2	–	Sell	-1,904	Closed	-$24K	–	1512
2019 Q1	$24K	Buy	+1,904	New	+$25.4K	0.01%	661

Point72 Hong Kong's FLXN Position: Q4 2021 in Review

Point72 Hong Kong sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 2,860 shares — an estimated $17K sold.

Point72 Hong Kong first reported a position in FLXN in Q1 2019 and held it in 6 quarters. The position peaked at $31K in Q2 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Point72 Hong Kong reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Point72 Hong Kong sold 2,860 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $17K.
Point72 Hong Kong first reported a position in Flexion Therapeutics, Inc. in Q1 2019 and held it in 6 quarters.
Point72 Hong Kong's Flexion Therapeutics, Inc. position peaked at $31K in Q2 2020.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.